Galapagos NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
06 mei 2015 - 07:51
Statutaire naam
Galapagos NV
Titel
Galapagos listed 10 years on Euronext Amsterdam and Brussels
Bericht
Mechelen, Belgium; 6 May 2015: Galapagos NV (Euronext: GLPG) rings the opening bell today at Euronext Amsterdam to celebrate 10 years as a listed company.
Ten years ago, on 5 May 2005, Galapagos completed its initial public offering with a dual listing in Amsterdam and Brussels. Since then, Galapagos has grown from 70 to over 400 employees and from €70 million to around €1.2 billion in market capitalization. Galapagos forms part of the Brussels BelMid Index and the Amsterdam Midcap Index. Galapagos recently reported positive results with its JAK1 inhibitor filgotinib in the DARWIN 1 and DARWIN 2 trials in nearly 900 rheumatoid arthritis patients worldwide; this was one of the research programs co-funded by the IPO in 2005.
Datum laatste update: 01 september 2024